* MIDAZOLAM NASAL SPRAY HAS ALSO BEEN GRANTED FAST TRACK DESIGNATION BY THE US FDA DUE TO THE HIGH UNMET NEED FOR PATIENTS AND CAREGIVERS * MIDAZOLAM NASAL SPRAY HAS BEEN GRANTED ORPHAN DRUG ...
Alert FDA OKs Midazolam Nasal Spray (Nayzilam) for Seizure Clusters Nayzilam is the first FDA-approved nasal option for treating seizure clusters that are distinct from a patient's usual seizure ...
The Phase 3 open-label extension (OLE) study evaluated the safety of repeated, intermittent use of NAYZILAM in individuals living with epilepsy experiencing acute repetitive seizures, also known as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback